These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27943173)

  • 21. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    Value Health; 2013; 16(2):231-50. PubMed ID: 23538175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On discounting of health gains from human papillomavirus vaccination: effects of different approaches.
    Westra TA; Parouty M; Brouwer WB; Beutels PH; Rogoza RM; Rozenbaum MH; Daemen T; Wilschut JC; Boersma C; Postma MJ
    Value Health; 2012 May; 15(3):562-7. PubMed ID: 22583467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On discount rates for economic evaluations in global health.
    Haacker M; Hallett TB; Atun R
    Health Policy Plan; 2020 Feb; 35(1):107-114. PubMed ID: 31625564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inconsistencies in the "societal perspective" on costs of the Panel on Cost-Effectiveness in Health and Medicine.
    Meltzer D; Johannesson M
    Med Decis Making; 1999; 19(4):371-7. PubMed ID: 10520672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness Analysis Appraisal and Application: An Emergency Medicine Perspective.
    April MD; Murray BP
    Acad Emerg Med; 2017 Jun; 24(6):754-768. PubMed ID: 28295894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discounting in the economic evaluation of health care interventions.
    Krahn M; Gafni A
    Med Care; 1993 May; 31(5):403-18. PubMed ID: 8501989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of the U.S. panel on cost-effectiveness in health and medicine.
    Phillips KA; Chen JL
    Am J Prev Med; 2002 Feb; 22(2):98-105. PubMed ID: 11818178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion.
    Claxton K; Sculpher M; Culyer A; McCabe C; Briggs A; Akehurst R; Buxton M; Brazier J
    Health Econ; 2006 Jan; 15(1):1-4. PubMed ID: 16365910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conducting systematic reviews of economic evaluations.
    Gomersall JS; Jadotte YT; Xue Y; Lockwood S; Riddle D; Preda A
    Int J Evid Based Healthc; 2015 Sep; 13(3):170-8. PubMed ID: 26288063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discounting health effects in pharmacoeconomic evaluations: current controversies.
    Bos JM; Postma MJ; Annemans L
    Pharmacoeconomics; 2005; 23(7):639-49. PubMed ID: 16173156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence to Discounting Guidelines: Evidence from Over 2000 Published Cost-Effectiveness Analyses.
    Kwok MQT; Kareem MA; Cash MJ; Lafferty F; Tobin K; O'Mahony JF
    Pharmacoeconomics; 2020 Aug; 38(8):809-818. PubMed ID: 32342439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [What is an efficient health technology in Spain?].
    Sacristán JA; Oliva J; Del Llano J; Prieto L; Pinto JL
    Gac Sanit; 2002; 16(4):334-43. PubMed ID: 12113733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case-studies of displacement effects in Dutch hospital care.
    Wammes JJG; Frederix G; Govaert P; Determann D; Evers S; Paulus A; Stadhouders N; Jeurissen P; Oortwijn W; Adang EMM
    BMC Health Serv Res; 2020 Mar; 20(1):263. PubMed ID: 32228590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A note on the depreciation of the societal perspective in economic evaluation of health care.
    Johannesson M
    Health Policy; 1995 Jul; 33(1):59-66. PubMed ID: 10143700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discounting in Economic Evaluations.
    Attema AE; Brouwer WBF; Claxton K
    Pharmacoeconomics; 2018 Jul; 36(7):745-758. PubMed ID: 29779120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The French National Authority for Health (HAS) Guidelines for Conducting Budget Impact Analyses (BIA).
    Ghabri S; Autin E; Poullié AI; Josselin JM
    Pharmacoeconomics; 2018 Apr; 36(4):407-417. PubMed ID: 29247437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6].
    Willke RJ; Neumann PJ; Garrison LP; Ramsey SD
    Value Health; 2018 Feb; 21(2):155-160. PubMed ID: 29477393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Future Directions for Cost-effectiveness Analyses in Health and Medicine.
    Neumann PJ; Kim DD; Trikalinos TA; Sculpher MJ; Salomon JA; Prosser LA; Owens DK; Meltzer DO; Kuntz KM; Krahn M; Feeny D; Basu A; Russell LB; Siegel JE; Ganiats TG; Sanders GD
    Med Decis Making; 2018 Oct; 38(7):767-777. PubMed ID: 30248277
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.